{"protocolSection":{"identificationModule":{"nctId":"NCT02138006","orgStudyIdInfo":{"id":"EPN-2012"},"organization":{"fullName":"Karolinska Institutet","class":"OTHER"},"briefTitle":"Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes","officialTitle":"Stockholm Diabetes Intervention Study","acronym":"SDIS"},"statusModule":{"statusVerifiedDate":"2016-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"1982-09"},"primaryCompletionDateStruct":{"date":"2011-12","type":"ACTUAL"},"completionDateStruct":{"date":"2011-12","type":"ACTUAL"},"studyFirstSubmitDate":"2014-05-09","studyFirstSubmitQcDate":"2014-05-12","studyFirstPostDateStruct":{"date":"2014-05-14","type":"ESTIMATED"},"resultsFirstSubmitDate":"2015-11-16","resultsFirstSubmitQcDate":"2015-11-16","resultsFirstPostDateStruct":{"date":"2015-12-21","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-08-31","lastUpdatePostDateStruct":{"date":"2016-10-24","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Thomas Nystrom","investigatorTitle":"dr","investigatorAffiliation":"Karolinska Institutet"},"leadSponsor":{"name":"Karolinska Institutet","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"To investigate long-term effects on cardiovascular mortality/morbidity and renal failure in type 1 diabetes patients former randomized to intensive insulin treatment","detailedDescription":"The Stockholm Diabetes Intervention Study (SDIS) aimed to determine whether intensified insulin treatment were feasible and led to less serious diabetic complications. 102 patients with type 1 diabetes mellitus were randomized (October 1982 to March 1984) to intensified conventional treatment (ICT; n=48) or standard treatment (ST; n=54). The randomized SDIS study lasted for 7.5 years, whereas 96 patients were fully evaluated. Thereafter patients were assigned to their regular clinical visits.\n\nIn the present interventional study we wanted to study all-cause mortality and cardiovascular outcomes (i.e. myocardial infarction and stroke), and renal failure in the SDIS cohort until december 31 2011."},"conditionsModule":{"conditions":["Coronary Heart Disease","Stroke","Renal Failure"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":102,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Intensive insulin treatment","type":"EXPERIMENTAL","description":"Intensive insulin treatment","interventionNames":["Drug: Intensive insulin treatment"]},{"label":"Standard insulin treatment","type":"ACTIVE_COMPARATOR","description":"Standard insulin treatment","interventionNames":["Drug: Standard insulin treatment"]}],"interventions":[{"type":"DRUG","name":"Intensive insulin treatment","description":"Mealtime insulin (Actrapid) Basal insulin (Monotard)","armGroupLabels":["Intensive insulin treatment"],"otherNames":["Basal-bolus insulin treatment"]},{"type":"DRUG","name":"Standard insulin treatment","description":"Insulin Mixtard","armGroupLabels":["Standard insulin treatment"],"otherNames":["Mixed insulin 2-3 times per day"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Cardiovascular Mortality","description":"All cause mortality and composite mortality from myocardial infarction, stroke and renal failure","timeFrame":"Up to 28 years"}],"secondaryOutcomes":[{"measure":"Morbidity of Cardiovascular Complications","description":"Morbidity of: coronary heart disease, stroke and renal failure","timeFrame":"Up to 28 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Born 1930 or later\n* Type 1 diabetes\n* Nonproliferative retinopathy\n* Normal serum creatinine\n* Unsatisfactory blood glucose control\n\nExclusion Criteria:\n\n* Alcohol/drug abuse\n* Proliferative retinopathy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"52 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Thomas Nyström, Md, PhD","affiliation":"Karolinska Institutet Dept of clinical science and education Södersjukhuset Stocholm","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Södersjukhuset","city":"Stockholm","zip":"11883","country":"Sweden","geoPoint":{"lat":59.33258,"lon":18.0649}}]},"referencesModule":{"references":[{"pmid":"8147960","type":"BACKGROUND","citation":"Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul 29;329(5):304-9. doi: 10.1056/NEJM199307293290502."},{"pmid":"8772731","type":"BACKGROUND","citation":"Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes. 1996 Sep;45(9):1253-8. doi: 10.2337/diab.45.9.1253."},{"pmid":"3048052","type":"BACKGROUND","citation":"Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand. 1988;224(2):115-22. doi: 10.1111/j.0954-6820.1988.tb16748.x."},{"pmid":"8288056","type":"BACKGROUND","citation":"Reichard P, Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes. 1994 Feb;43(2):313-7. doi: 10.2337/diab.43.2.313."},{"pmid":"24802206","type":"BACKGROUND","citation":"Rathsman B, Jensen-Urstad K, Nystrom T. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study. Diabetologia. 2014 Aug;57(8):1703-10. doi: 10.1007/s00125-014-3248-2. Epub 2014 May 7."}]},"ipdSharingStatementModule":{"ipdSharing":"YES"}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Intensive Insulin Treatment","description":"Intensive insulin treatment\n\nIntensive insulin treatment"},{"id":"FG001","title":"Standard Insulin Treatment","description":"Standard insulin treatment\n\nStandard insulin treatment"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"54"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"54"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Intensive Insulin Treatment","description":"Intensive insulin treatment\n\nIntensive insulin treatment"},{"id":"BG001","title":"Standard Insulin Treatment","description":"Standard insulin treatment\n\nStandard insulin treatment"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"102"}]}],"measures":[{"title":"Age, Categorical","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"102"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}]}]},{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30","spread":"8"},{"groupId":"BG001","value":"32","spread":"7"},{"groupId":"BG002","value":"31","spread":"7"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"54"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"22"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"48"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"Sweden","categories":[{"measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"54"},{"groupId":"BG002","value":"102"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Cardiovascular Mortality","description":"All cause mortality and composite mortality from myocardial infarction, stroke and renal failure","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"Up to 28 years","groups":[{"id":"OG000","title":"Intensive Insulin Treatment","description":"Intensive insulin treatment\n\nIntensive insulin treatment"},{"id":"OG001","title":"Standard Insulin Treatment","description":"Standard insulin treatment\n\nStandard insulin treatment"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"54"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"11"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.30","statisticalMethod":"Log Rank","ciNumSides":"TWO_SIDED"}]},{"type":"SECONDARY","title":"Morbidity of Cardiovascular Complications","description":"Morbidity of: coronary heart disease, stroke and renal failure","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"Up to 28 years","groups":[{"id":"OG000","title":"Intensive Insulin Treatment","description":"Intensive insulin treatment\n\nIntensive insulin treatment"},{"id":"OG001","title":"Standard Insulin Treatment","description":"Standard insulin treatment\n\nStandard insulin treatment"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"54"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"11"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","eventGroups":[{"id":"EG000","title":"Intensive Insulin Treatment","description":"Intensive insulin treatment\n\nIntensive insulin treatment","seriousNumAffected":0,"seriousNumAtRisk":48,"otherNumAffected":0,"otherNumAtRisk":48},{"id":"EG001","title":"Standard Insulin Treatment","description":"Standard insulin treatment\n\nStandard insulin treatment","seriousNumAffected":0,"seriousNumAtRisk":54,"otherNumAffected":0,"otherNumAtRisk":54}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":true},"pointOfContact":{"title":"Thomas Nyström","organization":"Karolinska Institutet Södersjukhuset","email":"thomas.nystrom@sodersjukhuset.se","phone":"+46704325214"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000006331","term":"Heart Diseases"},{"id":"D000003327","term":"Coronary Disease"},{"id":"D000003324","term":"Coronary Artery Disease"},{"id":"D000017202","term":"Myocardial Ischemia"}],"ancestors":[{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6805","name":"Diabetes Mellitus","relevance":"LOW"},{"id":"M6236","name":"Coronary Artery Disease","asFound":"Coronary Heart Disease","relevance":"HIGH"},{"id":"M6239","name":"Coronary Disease","asFound":"Coronary Heart Disease","relevance":"HIGH"},{"id":"M6807","name":"Diabetes Mellitus, Type 1","relevance":"LOW"},{"id":"M19196","name":"Myocardial Ischemia","asFound":"Coronary Heart Disease","relevance":"HIGH"},{"id":"M26408","name":"Renal Insufficiency","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","asFound":"Heart Disease","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"},{"abbrev":"BC19","name":"Gland and Hormone Related Diseases"},{"abbrev":"BC20","name":"Immune System Diseases"},{"abbrev":"BXS","name":"Urinary Tract, Sexual Organs, and Pregnancy Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000007328","term":"Insulin"},{"id":"C000557859","term":"Insulin, Globin Zinc"}],"ancestors":[{"id":"D000007004","term":"Hypoglycemic Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"}],"browseLeaves":[{"id":"M10055","name":"Insulin","asFound":"Per","relevance":"HIGH"},{"id":"M173072","name":"Insulin, Globin Zinc","asFound":"Per","relevance":"HIGH"},{"id":"M29489","name":"Biphasic Insulins","relevance":"LOW"},{"id":"M17458","name":"Zinc","relevance":"LOW"},{"id":"M9744","name":"Hypoglycemic Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"Hypo","name":"Hypoglycemic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Micro","name":"Micronutrients"}]}},"hasResults":true}